Abstract 158: Rescue Strategy for Failed Mechanical Thrombectomy in Acute Ischemic Stroke: An Analysis of the SVIN Registry
Aaron Rodriguez-Calienes,Juan Vivanco-Suarez,Diogo C Haussen,Mahmoud Mohammaden,Raul G Nogueira,Alhamza Al-Bayati,Ameer E Hassan,Wondwossen Tekle,Sohum Desai,Hamzah Saei,Fifi Johanna,Shahram Majidi,Stavros Matsoukas,James E Siegler,Pratit Patel,Tudor G Jovin,Sunil Sheth,Sergio Salazar-Marioni,Ananya Iyyangar,Thanh Nguyen,Mohamad AbdalKader,Italo Linfante,Guilherme Dabus,Brijesh P Mehta,Joy Sessa,Mouhammad A Jumaa,Rebecca M Sugg,Adeel Saleemi,Guillermo Linares,Fazeel M Siddiqui,Santiago Ortega-Gutierrez
DOI: https://doi.org/10.1161/str.55.suppl_1.158
IF: 10.17
2024-02-01
Stroke
Abstract:Background: Mechanical thrombectomy (MT) fails to achieve successful reperfusion in up to 20% of large vessel occlusions (LVOs). Rescue strategies (RS) have shown promise in multicenter studies and meta-analyses. We aimed to evaluate the association between RS with functional outcomes compared to medical management (MM) in patients who underwent failed MT. Methods: This is a cross-sectional study using prospectively collected data from the Society of Vascular and Interventional Neurology (SVIN) Registry from 2018 to 2021. We included all adult patients with anterior circulation LVOs who experienced a failed MT (mTICI 0-2a after multiple attempts to clot retrieval) at the 14 participating centers. The patients were divided into two groups: those who received RS (including balloon angioplasty alone, intracranial stenting with or without balloon angioplasty) and those who only received MM. The primary outcome was the shift in the degree of disability, as measured by the mRS at 90 days. Additional outcomes included functional independence (90-day mRS score of 0-2), sICH, and mortality at 90 days. Results: A total of 642 patients were included in the analysis. The RS group consisted of 294 (45.8%) patients, while the MM group comprised 348 (54.2%) patients. A mTICI score of 2b-3 was achieved in 242/293 (82.6%) patients in the RS group. After adjusting for confounders, the RS group showed a favorable shift in the overall 90-day mRS distribution (acOR=1.97, 95%CI 1.36-2.85, p =<0.001) and higher rates of functional independence (RS: 30.7% vs. MM: 12%, aOR=2.39, 95%CI 1.34-4.26, p =0.003) ( Figure ) compared to the MM group. RS also showed lower rates of sICH (RS: 2.7% vs. MM: 9%, aOR=0.32, 95%CI 0.14-0.71, p =0.005) and 90-day mortality (RS: 29.5% vs. MM: 49.7%, aOR=0.49, 95%CI 0.33-0.74, p =<0.001). Conclusion: Our findings support the use of RS as a potential alternative for stroke patients with failed MT. Further prospective studies are needed to validate these observations.
peripheral vascular disease,clinical neurology